Charbel Khalil

670 total citations
19 papers, 466 citations indexed

About

Charbel Khalil is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Charbel Khalil has authored 19 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 4 papers in Genetics. Recurrent topics in Charbel Khalil's work include Mesenchymal stem cell research (8 papers), Virus-based gene therapy research (3 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Charbel Khalil is often cited by papers focused on Mesenchymal stem cell research (8 papers), Virus-based gene therapy research (3 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Charbel Khalil collaborates with scholars based in Lebanon, France and United States. Charbel Khalil's co-authors include Nada Alaaeddine, George Hilal, Mayssam Moussa, Daniel Lajeunesse, Oula El Atat, Nehman Makdissy, María P. De Miguel, Jorge L. Alió del Barrio, Walid Harb and Mona El Zarif and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and The FASEB Journal.

In The Last Decade

Charbel Khalil

18 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charbel Khalil Lebanon 8 145 122 115 106 82 19 466
Stéphane Maddens France 14 107 0.7× 109 0.9× 201 1.7× 177 1.7× 21 0.3× 21 636
Ayaka Toda Japan 6 172 1.2× 53 0.4× 242 2.1× 87 0.8× 30 0.4× 8 434
Jun Zou China 14 209 1.4× 23 0.2× 95 0.8× 116 1.1× 66 0.8× 42 649
Catherine Alexakis France 10 41 0.3× 24 0.2× 138 1.2× 249 2.3× 34 0.4× 11 494
Fen Zhang China 7 502 3.5× 74 0.6× 196 1.7× 75 0.7× 214 2.6× 9 662
Nicholas L. Occleston United Kingdom 8 159 1.1× 21 0.2× 94 0.8× 88 0.8× 50 0.6× 9 476
Jorge Saá Spain 6 47 0.3× 30 0.2× 139 1.2× 129 1.2× 51 0.6× 7 417
Heike Cappallo‐Obermann Germany 9 37 0.3× 70 0.6× 148 1.3× 190 1.8× 108 1.3× 12 559
Dawiyat Massoudi United States 11 108 0.7× 27 0.2× 30 0.3× 103 1.0× 48 0.6× 18 329
Laurent Bégot France 6 30 0.2× 266 2.2× 269 2.3× 88 0.8× 16 0.2× 10 621

Countries citing papers authored by Charbel Khalil

Since Specialization
Citations

This map shows the geographic impact of Charbel Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charbel Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charbel Khalil more than expected).

Fields of papers citing papers by Charbel Khalil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charbel Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charbel Khalil. The network helps show where Charbel Khalil may publish in the future.

Co-authorship network of co-authors of Charbel Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Charbel Khalil. A scholar is included among the top collaborators of Charbel Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charbel Khalil. Charbel Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rafii, Saeed, et al.. (2025). Advancing CAR T-Cell Therapy in Solid Tumors: Current Landscape and Future Directions. Cancers. 17(17). 2898–2898. 3 indexed citations
2.
Sokhn, Elie Salem, et al.. (2025). Antimicrobial activity of adipose-derived mesenchymal stromal cell secretome against methicillin-resistant Staphylococcus aureus. Stem Cell Research & Therapy. 16(1). 21–21. 2 indexed citations
4.
Khalil, Charbel, et al.. (2024). Mesenchymal Stem Cell-Derived Secretome-Based Therapy for Neurological Disorders: A Scoping Review. 14(1). 1–19. 1 indexed citations
5.
Kourié, Hampig Raphaël, et al.. (2024). Genome Engineering as a Therapeutic Approach in Cancer Therapy: A Comprehensive Review. SHILAP Revista de lepidopterología. 5(1). 2300201–2300201. 1 indexed citations
6.
Ghosn, Marwan, et al.. (2024). Anti-aging based on stem cell therapy: A scoping review. PubMed. 14(3). 97233–97233. 5 indexed citations
7.
Khalil, Charbel, et al.. (2023). T-cell lymphocytes’ aging clock: telomeres, telomerase and aging. Biogerontology. 25(2). 279–288. 10 indexed citations
8.
Harb, Frédéric, et al.. (2023). Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications. Clinical & Translational Oncology. 25(7). 2056–2068. 21 indexed citations
9.
Kim, Joo Yeon, Charbel Khalil, David Kim, et al.. (2023). Influence of Age, Sex, and Wait Times on Public Online Ratings of Glaucoma Physicians in the United States. Journal of Glaucoma. 32(7). 609–612. 1 indexed citations
10.
Wenceslau, Cristiane Valverde, et al.. (2022). Therapeutic Potential of Human Immature Dental Pulp Stem Cells Observed in Mouse Model for Acquired Aplastic Anemia. Cells. 11(14). 2252–2252. 5 indexed citations
11.
Khalil, Charbel, et al.. (2021). Autologous Adipose-Derived Mesenchymal Stem Cells Embedded in Platelet-Rich Fibrin in Diabetic Foot Ulcers. 10(2). 19–30. 4 indexed citations
12.
Araldi, Rodrigo Pinheiro, Charbel Khalil, Thatiana Corrêa de Melo, et al.. (2020). Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview. Gene. 745. 144636–144636. 19 indexed citations
13.
Barrio, Jorge L. Alió del, Mona El Zarif, Nehman Makdissy, et al.. (2019). Regenerative Surgery of the Corneal Stroma for Advanced Keratoconus: 1-Year Outcomes. American Journal of Ophthalmology. 203. 53–68. 61 indexed citations
14.
Khalil, Charbel, et al.. (2019). Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study. Journal of Ovarian Research. 12(1). 70–70. 38 indexed citations
15.
Moussa, Mayssam, et al.. (2019). Abstract 3596: The combinatory effect of bevacizumab and metabolic inhibitors on angiogenesis and autophagy in gastrointestinal cancer cells. Cancer Research. 79(13_Supplement). 3596–3596. 1 indexed citations
16.
Khalil, Charbel, Raquel Díaz, Angélica Escobar, et al.. (2018). Genome Sequence of Hydrogenovibrio sp. Strain SC-1, a Chemolithoautotrophic Sulfur and Iron Oxidizer. Genome Announcements. 6(5). 5 indexed citations
17.
Moussa, Mayssam, Daniel Lajeunesse, George Hilal, et al.. (2017). Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage. Experimental Cell Research. 352(1). 146–156. 174 indexed citations
18.
Barrio, Jorge L. Alió del, Mona El Zarif, Nehman Makdissy, et al.. (2017). Corneal Stroma Enhancement With Decellularized Stromal Laminas With or Without Stem Cell Recellularization for Advanced Keratoconus. American Journal of Ophthalmology. 186. 47–58. 85 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026